1. Home
  2. CCB vs ABCL Comparison

CCB vs ABCL Comparison

Compare CCB & ABCL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Coastal Financial Corporation

CCB

Coastal Financial Corporation

HOLD

Current Price

$73.43

Market Cap

1.1B

Sector

Finance

ML Signal

HOLD

Logo AbCellera Biologics Inc.

ABCL

AbCellera Biologics Inc.

HOLD

Current Price

$5.27

Market Cap

1.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CCB
ABCL
Founded
1997
2012
Country
United States
Canada
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.1B
1.3B
IPO Year
2018
2020

Fundamental Metrics

Financial Performance
Metric
CCB
ABCL
Price
$73.43
$5.27
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
5
Target Price
$126.67
$8.40
AVG Volume (30 Days)
92.1K
7.2M
Earning Date
04-29-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
10.91
EPS
0.78
N/A
Revenue
N/A
$75,128,000.00
Revenue This Year
$96.61
N/A
Revenue Next Year
$22.66
$21.85
P/E Ratio
$92.29
N/A
Revenue Growth
N/A
160.56
52 Week Low
$66.50
$2.75
52 Week High
$120.05
$6.79

Technical Indicators

Market Signals
Indicator
CCB
ABCL
Relative Strength Index (RSI) 55.28 51.77
Support Level $73.44 $3.42
Resistance Level $79.50 $5.63
Average True Range (ATR) 1.91 0.55
MACD 0.66 -0.11
Stochastic Oscillator 99.11 16.10

Price Performance

Historical Comparison
CCB
ABCL

About CCB Coastal Financial Corporation

Coastal Financial Corp is a bank holding company. Through its subsidiaries, the company conducts its business in three reportable segments which include, Community Bank, CCBX, and Treasury and Administration. The Community Bank segment includes all community banking activities, with a primary focus on providing various banking products and services to consumers and small to medium-sized businesses. The CCBX segment provides Banking as a Service (BaaS) that allows its broker dealers and digital financial service partners to offer their customers banking services, and the Treasury and administration segment includes treasury management, overall administration, and all other aspects of the company.

About ABCL AbCellera Biologics Inc.

AbCellera Biologics Inc is a clinical-stage biotechnology company focused on discovering and developing first-in-class antibody medicines for indications with high unmet medical need. It has built a platform for advancing antibody drug programs that the company believes provides it with a competitive advantage in addressing challenging, high-value targets such as complex transmembrane proteins and novel modalities, including multispecifics and antibody-drug conjugates. Organisation's pipeline includes two drug candidates in clinical development, two development candidates in Investigational New Drug (IND/Clinical Trial Application (CTA)-enabling activities, and more than 20 active discovery programs across multiple modalities and indications.

Share on Social Networks: